(hide)
A study of 733 breast cancer cases for 10 SNPs concluded that
the rs1501299(C;C) genotype (in dbSNP orientation) was at increased risk (odds
ratio 1.80, CI: 1.14 - 2.85). After categorizing individuals by adiponectin
signaling status, this study found that compared with high signalers,
intermediate signalers had a 4.16-fold increase in breast cancer risk (CI:
0.49-35.19), and low signalers had a 6.56x higher breast cancer risk (CI:
0.78-54.89, p(trend) = 0.001). Adiponectin signaling status was assigned as
follows: rs1501299(G,G) + rs2241766(T,T) = low signaler<br>
rs1501299(G,T) + rs2241766(T,T) = low signaler<br> rs1501299(G,G)
+ rs2241766(G,T) = low signaler<br> rs1501299(T,T) +
rs2241766(T,T) = intermediate signaler<br> rs1501299(G,T) +
rs2241766(G,T) = intermed...